Journal: Antioxidants (Basel, Switzerland)
Article Title: Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy.
doi: 10.3390/antiox10121920
Figure Lengend Snippet: Figure 1. Hidrosmin-related effects on viability and cytotoxicity of HK2 cells: (a) MTT cell viability at 24, 48, and 72 h of incubation in medium with 0.5% FBS containing hidrosmin (H, 0.3 and 1 mM), vehicle of 1mM hidrosmin (0.5% DMSO), 20% FBS (positive control, C+), and 10% DMSO (negative control, C−); (b) BrdU cell proliferation assay at 24, 48, and 72 h incubation in medium with 10% FBS containing hidrosmin (H, 0.1, 0.3 and 1 mM), vehicle (0.5% DMSO), 20% FBS (C+) and 10% DMSO (C−). Bars represent the mean ± SEM of 6 experiments. *** p < 0.001 vs. basal (black line).
Article Snippet: Human kidney 2 (HK2) proximal tubular cell line (ATCC Cat# CRL-2190, RRID:CVCL_0302; Manassas, VA, USA) was maintained in RPMI supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine (Sigma-Aldrich, Saint Louis, MO, USA), 1% insulin–transferrin–selenium (Thermo Fisher Scientific) and 36 ng/mL hydrocortisone (Sigma-Aldrich).
Techniques: Incubation, Positive Control, Negative Control, BrdU Cell Proliferation Assay